Search results
Results from the WOW.Com Content Network
Attention deficit hyperactivity disorder management options are evidence-based practices with established treatment efficacy for ADHD.Approaches that have been evaluated in the management of ADHD symptoms include FDA-approved pharmacologic treatment and other pharmaceutical agents, psychological or behavioral approaches, combined pharmacological and behavioral approaches, cognitive training ...
Attention deficit hyperactivity disorder; Other names: Formerly: Attention deficit disorder (ADD), hyperkinetic disorder (HD) [1]: ADHD arises from maldevelopment in brain regions such as the prefrontal cortex, basal ganglia and anterior cingulate cortex, which regulate the executive functions necessary for human self-regulation.
Nomifensine (Dual selective norepinephrine–dopamine reuptake inhibitor (NDRI) is a drug used for the treatment of clinical depression, attention deficit hyperactivity disorder (ADHD), narcolepsy, and the management of Parkinson's disease. Phenylpiracetam; Isopropylphenidate [16] Rimcazole; Venlafaxine (weak)
Hyperfocus is an intense interest in or passion for something that's goal-oriented, Adler continues. There's even research that hyperfocus can create a state of deep concentration for some people ...
Hyperfocus is an intense form of mental concentration or visualization that focuses consciousness on a subject, topic, or task. In some individuals, various subjects or topics may also include daydreams , concepts , fiction , the imagination , and other objects of the mind .
Adult Attention Deficit Hyperactivity Disorder is the persistence of attention deficit hyperactivity disorder (ADHD) into adulthood. It is a neurodevelopmental disorder, meaning impairing symptoms must have been present in childhood, except for when ADHD occurs after traumatic brain injury.
For premium support please call: 800-290-4726 more ways to reach us
Dimemorfan (or dimemorphan) (brand names Astomin, Dastosirr, Tusben), or dimemorfan phosphate (), also known as 3,17-dimethylmorphinan, is an antitussive (cough suppressant) of the morphinan family that is widely used in Japan and is also marketed in Spain and Italy.